logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

sgp-lg.png
+

SGP Stock Price, News & Analysis

06 Feb Stock Analysis
4a39ac79965dbdc4c586d12ea5141f62.jpeg
+

Assessing Archer Aviation (ACHR) After Recent Share Price Weakness

06 Feb Stock Analysis

recent post

  • sgp-lg.png

    SGP Stock Price, News & Analysis

    Feb 06 2026
  • 108262123-1770318565681-gettyimages-1329055819-bitcoin-chart.jpeg

    Bitcoin gets slashed in half. What’s

    Feb 06 2026
  • 4a39ac79965dbdc4c586d12ea5141f62.jpeg

    Assessing Archer Aviation (ACHR) After Recent

    Feb 06 2026
  • bitthumb1-1200x675.jpg

    South Korean Crypto Exchange Accidentally Gave

    Feb 06 2026
  • 1585186820973.jpeg

    Is Deutsche Bank (XTRA:DBK) Pricing Reflect

    Feb 06 2026

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.